United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $773,721,457.77
- Nov. 11, 2024
- Martine A Rothblatt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 18, 2013 | CFO | 9,000 | $69.85 | Sell | $628,650.00 | |
| July 11, 2013 | CEO | 3,837 | $67.94 | Sell | $260,685.78 | |
| July 5, 2013 | Director | 1,500 | $66.33 | Sell | $99,495.00 | |
| July 5, 2013 | CEO | 3,863 | $67.28 | Sell | $259,902.64 | |
| July 5, 2013 | COO | 10,000 | $67.21 | Sell | $672,100.00 | |
| July 5, 2013 | EVP | 6,000 | $67.04 | Sell | $402,240.00 | |
| June 21, 2013 | COO | 10,000 | $63.34 | Sell | $633,400.00 | |
| June 20, 2013 | CFO | 4,500 | $63.22 | Sell | $284,490.00 | |
| June 20, 2013 | EVP | 6,000 | $63.29 | Sell | $379,740.00 | |
| June 7, 2013 | COO | 10,000 | $67.00 | Sell | $670,000.00 | |
| June 6, 2013 | EVP | 6,000 | $63.84 | Sell | $383,040.00 | |
| June 6, 2013 | CFO | 4,500 | $64.84 | Sell | $291,780.00 | |
| June 6, 2013 | Director | 3,000 | $63.77 | Sell | $191,310.00 | |
| May 17, 2013 | COO | 10,000 | $69.17 | Sell | $691,700.00 | |
| May 16, 2013 | CFO | 4,500 | $68.48 | Sell | $308,160.00 | |
| May 16, 2013 | EVP | 6,000 | $68.05 | Sell | $408,300.00 | |
| May 2, 2013 | Director | 3,000 | $66.75 | Sell | $200,250.00 | |
| May 2, 2013 | EVP | 6,000 | $67.15 | Sell | $402,900.00 | |
| April 11, 2013 | Director | 9,000 | $61.35 | Sell | $552,150.00 | |
| Jan. 17, 2013 | EVP | 5,749 | $52.20 | Sell | $300,097.80 | |
| Dec. 28, 2012 | CEO | 4,167 | $52.40 | Buy | $218,350.80 | |
| Dec. 26, 2012 | CEO | 6,000 | $52.40 | Buy | $314,400.00 | |
| Dec. 21, 2012 | CEO | 9,000 | $51.85 | Buy | $466,650.00 | |
| Nov. 26, 2012 | Director | 1,500 | $53.33 | Sell | $79,995.00 | |
| Oct. 4, 2012 | Director | 1,500 | $58.33 | Sell | $87,495.00 | |
| Oct. 4, 2012 | CFO | 1,550 | $58.00 | Sell | $89,900.00 | |
| Oct. 4, 2012 | EVP | 6,000 | $38.00 | Sell | $228,000.00 | |
| Sept. 6, 2012 | Director | 1,500 | $55.94 | Sell | $83,910.00 | |
| Sept. 5, 2012 | Director | 2,000 | $55.47 | Sell | $110,940.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.